+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07885410

Patient Views on Changing Treatment in Cystic Fibrosis From ETI to VTD Observational Study

Led by Fondation Ildys · Updated on 2026-10-28

343

Participants Needed

12

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research investigates how adults with cystic fibrosis feel about switching from their current treatment with elexacaftortezacaftorivacaftor ETI to a newer therapy called vanzacaftortezacaftordeutivacaftor VTD. It focuses on patients willingness to change treatments and examines factors like treatment satisfaction, knowledge about VTD, quality of life, and concerns related to side effects and access. The study includes both questionnaires and interviews to understand patients views and decision-making. Participants include adults treated with ETI for at least three months or those who stopped ETI for medical reasons. The study does not require participants to change treatments but observes their preferences and related characteristics. Data are collected through specific questionnaires during routine visits or hospital stays, and some participants take part in detailed interviews lasting 30 to 45 minutes. The study collects information on quality of life, treatment adherence, and adverse effects from medical records. Throughout the study, participants complete questionnaires at one time point, and a smaller group participates in interviews to explore psychological and logistical challenges. Researchers analyze responses to understand intentions to switch treatment and identify support needs. The study is observational, with data collection integrated into routine care, and is expected to include about 343 participants for the questionnaires and 8 to 12 for interviews. Participation lasts for the duration of data collection around a routine visit or hospital stay.

CONDITIONS

Brief Title

PERCE-MUCO: Perceptions and Expectations of People With Cystic Fibrosis Regarding a Change in Treatment

Research Team

M

Morgane Auffret, ResearchNurse

M

Matthieu Pichelin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here